ACC Report 2015: Long-term Ticagrelor protective against post-heart attack events for beyond one year
by Bruce Sylvester: The addition of antiplatelet drug ticagrelor to aspirin for long-term post-heart attack therapy has reduced the rate of mortality from subsequent cardiovascular causes, heart attack… read more.